News

The Phase II trial of the pandemic influenza (H5N1) whole viron inactivated vaccine included 402 volunteers, between the ages of 18 and 60, who were each vaccinated with

Net proceeds to AspenBio totaled approximately $17.1 million and will be used to fund R&D, product development, FDA approval related activities, working capital and general corporate purposes. Richard

The shares of AMDL common stock were sold at $3.09 per share and the four-year warrants included in the units are exercisable at $4.74 per share. Warrants to

The proceeds from this financing will enable Romark to advance development of its lead compound, nitazoxanide, for the treatment of hepatitis C, and advance its next-generation thiazolide drug

This submission supports the proposed use of oral alitretinoin in severe refractory chronic hand eczema. Marketing applications for the use of alitretinoin in the treatment of severe chronic

Under the new terms for MIV-310, Mefuvir will finance the clinical development towards registration in Asia. Mefuvir has the marketing rights in Asia except Japan. Medivir retains the

As a result of the expanded CE Mark, the Taxus Liberte stent system in the EU is indicated for treatment of de novo and restenotic lesions or total

The company expects to initiate a limited launch of RenalGuard in the first quarter of 2008 in Italy, targeting early adoptors who recognize the benefits of utilizing the

Subject to the satisfaction of customary closing conditions, the transaction is expected to close on or about December 24, 2007. Net proceeds from the transaction will be used